De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
United Laboratories International Holdings Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
United Laboratories International Holdings heeft een totaal eigen vermogen van CN¥13.6B en een totale schuld van CN¥2.4B, wat de schuld-eigenvermogensverhouding op 18% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥22.8B en CN¥9.3B. De EBIT United Laboratories International Holdings is CN¥3.4B waardoor de rentedekking -58.1 is. Het heeft contanten en kortetermijnbeleggingen van CN¥6.6B.
Belangrijke informatie
18.0%
Verhouding schuld/eigen vermogen
CN¥2.44b
Schuld
| Rente dekkingsratio | -58.1x |
| Contant | CN¥6.55b |
| Aandelen | CN¥13.57b |
| Totaal verplichtingen | CN¥9.25b |
| Totaal activa | CN¥22.83b |
Recente financiële gezondheidsupdates
United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14
Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20
Recent updates
Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching
Aug 30Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified
Feb 29The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement
Jan 04United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case
Nov 26Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?
Aug 10United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?
Oct 19Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?
Mar 08The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It
Feb 18The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 03Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?
Jan 19We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide
Jan 04These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?
Dec 07The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?
Nov 23Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( CN¥15.1B ) 3933 } overtreffen de korte termijn passiva ( CN¥7.4B ).
Langlopende schulden: De kortetermijnactiva 3933 ( CN¥15.1B ) overtreffen de langetermijnschulden ( CN¥1.8B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 3933 heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van 3933 is de afgelopen 5 jaar gedaald van 70.1% naar 18%.
Schuldendekking: De schuld van 3933 wordt goed gedekt door de operationele kasstroom ( 126.6% ).
Rentedekking: 3933 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.